Antimycobacterial activity of lichen substances

Phytomedicine

Volumn 17, Issue 5, 2010, Pages 328-332

  Honda, N K ^a   Pavan, F R ^b   Coelho, R G ^a   de Andrade Leite, S R ^b   Micheletti, A C ^a   Lopes, T I B ^a   Misutsu, M Y ^a   Beatriz, A ^a   Brum, R L ^a   Leite, C Q F ^b  

^a FEDERAL UNIVERSITY OF MATO GROSSO DO SUL   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Diffractaic acid; Lichens; Mycobacterium tuberculosis; Phenolic products derivatives; Tuberculostatic activity

Indexed keywords

3 O METHYL 6 O BENZYL NORLICHEXANTHONE; 3,6 BIS[(3,3 DIMETHYLOXIRON 2 YL)METHOXY] 1 HYDROXY 8 METHYL XANTHONE; 3,6 DI O PRENYL NORLICHEXANTHONE; 8',9' DI O BUTYL SALAZINIC ACID; 8',9' DI O HEXYL SALAZINIC ACID; 8',9' DI O ISOPROPYL SALAZINIC ACID; 8',9' DI O PENTYL SALAZINIC ACID; 8',9' DI O PROPYL SALAZINIC ACID; ATRANORIN; BUTYL ORSELLINATE; DIFFRACTAIC ACID; HEXYL ORSELLINATE; HYPOSTICTIC ACID; ISONIAZID; ISOPROPYL ORSELLINATE; LECANORIC ACID; LICHEXANTHONE; NORLICHEXANTHONE; NORSTICTIC ACID; ORSELLINIC ACID ETHYL ESTER; ORSELLINIC ACID METHYL ESTER; PROPYL ORSELLINATE; PROTOCETRARIC ACID; SALAZINIC ACID; SECALONIC ACID; TERT BUTYL ORSELLINATE; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG; USNIC ACID;

ANTIBACTERIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG ISOLATION; DRUG STRUCTURE; LICHENS; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM AURUM; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PARMOTREMA DILATATUM; PARMOTREMA TINCTORUM; PRIORITY JOURNAL; PSEUDOPARMELIA SPHAEROSPORA; USNEA SUBCAVATA;

ANTITUBERCULAR AGENTS; LICHENS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; PHENOLS; PLANT EXTRACTS; USNEA;

MYCOBACTERIUM TUBERCULOSIS; PARMOTREMA; PARMOTREMA TINCTORUM; PSEUDOPARMELIA; SPHAEROSPORA; USNEA;

EID: 76749162739     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phymed.2009.07.018     Document Type: Article

References (21)

1. Ahmann B., and Mathey A. Lecanoric acid and some constituents of Parmotrema tinctorum and Pseudevernia intense. The Bryologist 70 (1967) 93-97
2. Barreiro E.J., and Fraga C.A.M. Química Medicinal (2001), Artmed, Porto Alegre p. 243
3. Bapela N.B., Lall N., Fourie P.B., Franzblau S.G., and Van Rensburg C.E.J. Activity of 7-methyljuglone in combination with antituberculous drugs against Mycobacterium tuberculosis. Phytomedicine 13 (2006) 630-635
4. Caballeira N.M. New advances in fatty acids as antimalarial, antimycobacterial and antifungal agents. Prog. Lipid Res. 47 (2008) 50-61
5. Copp B.R., and Pearce N. Natural product growth inhibitors of Mycobacterium tuberculosis. Nat. Prod. Rep. 24 (2007) 278-297
6. Collins L.A., and Franzblau S.G. Microplate Alamar Blue Assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium. Antimicrob. Agents Chemother. 41 (1997) 1004-1009
7. Franzblau S.G., Witzig R.S., McLaughlin J.C., Torres P., Madico G., Hernandez A., et al. Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar Blue assay. J. Clin. Microbiol. 36 (1998) 362-366
8. Gomes A.T., Honda N.K., Roese F.M., Muzzi R.M., and Sauer L. Cytotoxic activity of Orsellinates. Z. Naturforsch. C: Biosci. 61 (2006) 653-657
9. Gupta V.K., Arokar M.P., Saikia D., Pal A., Fatima A., et al. Antimycobacterial activity of lichens. Pharm. Biol. 45 (2007) 200-204
10. Hale Jr. M.E. The Biology of Lichens. third ed. (1983), Edward Arnold, London
11. http://www.who.int/topics/tuberculosis/en - accessed January 21, 2009.
12. Ingólfsdóttir K., Chung G.A.C., Skúlason V.G., Gissurarson S.R., and Vilhelmdóttir M. Antimycobacterial activity of lichen metabolites in vitro. Eur. J. Pharm. Sci. 6 (1998) 141-144
13. Koul A., Vranckx L., Denouga N., Balemans W., Van Den Wyngaert I., et al. Diarylquinolines are bactericidal for dormant mycobacteria as a result of disturbed ATP homeostasis. J. Biol. Chem. 282 (2008) 25273-25280
14. Lenaerts A.J., DeGroote M.A., and Orme I.M. Preclinical testing of new drugs for tuberculosis: current challenges. Trends Microbiol. 16 (2007) 48-54
15. Lopes T.I.B., Coelho R.G., Yoshida N.C., and Honda N.K. Radical-scavenging activity of orsellinates. Chem. Pharm. Bull. 56 (2008) 1551-1554
16. Micheletti A.C., Beatriz A., de Lima D.P., and Honda N.K. Constituintes químicos de Parmotrema lichexanthonicum Eliasaro & Adler - Isolamento, Modificações estruturais e avaliação das atividades antibiótica e citotóxica. Quim. Nova 32 (2009) 12-20
17. Micheletti, A.C., 2007. Preparação de derivados de xantona e depsidona e avaliação da atividade biológica. Dissertation, UFMS, Campo Grande, p. 233.
18. Quenelle D.C., Winchester G.A., and Staas J.K. Treatment of tuberculosis using a combination of sustained-release rifampin-loaded microspheres and oral dosing with isoniazid. Antimicrob. Agents Chemother. 45 (2001) 1637-1644
19. Suksamrarn S., Suwannapoch N., Phakhoee W., Thanchranlert J., Ratananukul P., et al. Antimycobacterial activity of prenylated xanthones from the fruits of Garcinia mangostana. Chem. Pharm. Bull. 51 (2003) 857-859
20. Vartia K.O. Antibiotics in lichens. In: Ahmadjian V., and Hale M.E. (Eds). The Lichens (1973), Academic Press, New York 547-561
21. Wagner H., and Ulrich-Merzenich G. Synergy research: approaching a new generation of phytopharmaceuticals. Phytomedicine 16 (2009) 97-110